Dialysis News and Research

Latest Dialysis News and Research

Winners of Renal Support Network's 13th Annual Essay Contest announced

Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.

16 Sep 2015

Ninth annual Tour DaVita bike event to be held in NC to raise awareness on kidney disease

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, announces North Carolina as the host of the ninth annual Tour DaVita bike event.

15 Sep 2015

UT Southwestern evaluates allopurinol drug to prevent nephropathy in Type I diabetes patients

UT Southwestern Medical Center has joined an international clinical trial studying whether a drug traditionally used to treat gout can help prevent kidney damage in patients with Type 1 diabetes.

15 Sep 2015

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Sun Biomedical Limited today announced the first patient had been enrolled in a Phase II study of DMX-200, an innovative new treatment that combines two different drugs to treat chronic kidney disease.

15 Sep 2015

Study may help scientists to better understand complications caused by drug therapy in kidney transplant patients

New research will help scientists and medical professionals to better understand the long-term complications caused by an immunosuppressant drug used to treat thousands of kidney transplant patients.

11 Sep 2015

DCR launches Biospecimen Research Grant Program

DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.

8 Sep 2015

TMIGD1 protein could be a novel target for restoring kidney function from kidney disease

A new discovery by Boston University School of Medicine (BUSM) researchers may change how kidney disease is treated in the future.

3 Sep 2015

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy. If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously.

3 Sep 2015

Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced that Sanofi notified Ardelyx of its termination of the option and license agreement for Ardelyx's portfolio of NaP2b inhibitors effective September 30, 2015.

2 Sep 2015

DaVita Kidney Care to establish kidney care specialty hospital chain in Shandong province China

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading global provider of kidney care services, today announced it is forming a joint venture kidney care specialty hospital chain in Shandong province China.

31 Aug 2015

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.

27 Aug 2015

U.S. Renal Care, DSI Renal sign definitive merger agreement

U.S. Renal Care, Inc. and DSI Renal announced Monday they have entered into a definitive merger agreement. USRC is the third largest dialysis provider in the country, and when combined with DSI, the company will serve approximately 23,000 patients across 33 states and the Territory of Guam.

26 Aug 2015

WHO provides emergency health access to internally displaced persons, host communities in Taiz and Hodeida governorates

In response to the growing humanitarian crisis in Tiaz and Hodeida governorates, and the rising number of civilian injuries in the southern governorates of Yemen, WHO is coordinating a rapid response to provide emergency health access to the injured, internally displaced persons and host communities.

25 Aug 2015

Wyss Institute scientists develop improved blood-cleansing therapeutic device to treat sepsis

Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic.

21 Aug 2015

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardiance (empagliflozin) in more than 7,000 adults with type 2 diabetes (T2D) at high risk for CV events.

20 Aug 2015

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.

18 Aug 2015

DaVita HealthCare Partners hosts health and disaster preparedness fair in Colorado Springs

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, is hosting a health and disaster preparedness fair on Saturday, Aug. 22, at the St. Francis Medical Center off Woodmen Road in Colorado Springs.

18 Aug 2015

Quanta receives i4i award from NIHR to develop new product concept for nocturnal haemodialysis

Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received an Invention for Innovation (i4i) award worth £1.85 million from the National Institute for Health Research - the research arm of the NHS - to develop a new product concept for nocturnal haemodialysis.

18 Aug 2015

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

NxStage Medical, Inc., a leading manufacturer of dialysis products, today announced that the NxStage System One is now used in eight of the Top 10 Nephrology Hospitals in the United States as ranked according to U.S. News & World Report.

12 Aug 2015

Ardelyx reports net income of $9.0 million for second quarter 2015

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced financial results for the second quarter ended June 30, 2015.

12 Aug 2015

Dialysis News and Research

Latest Dialysis News and Research

Winners of Renal Support Network's 13th Annual Essay Contest announced

Ninth annual Tour DaVita bike event to be held in NC to raise awareness on kidney disease

UT Southwestern evaluates allopurinol drug to prevent nephropathy in Type I diabetes patients

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Study may help scientists to better understand complications caused by drug therapy in kidney transplant patients

DCR launches Biospecimen Research Grant Program

TMIGD1 protein could be a novel target for restoring kidney function from kidney disease

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors

DaVita Kidney Care to establish kidney care specialty hospital chain in Shandong province China

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

U.S. Renal Care, DSI Renal sign definitive merger agreement

WHO provides emergency health access to internally displaced persons, host communities in Taiz and Hodeida governorates

Wyss Institute scientists develop improved blood-cleansing therapeutic device to treat sepsis

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

DaVita HealthCare Partners hosts health and disaster preparedness fair in Colorado Springs

Quanta receives i4i award from NIHR to develop new product concept for nocturnal haemodialysis

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

Ardelyx reports net income of $9.0 million for second quarter 2015

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Dialysis News and Research

Latest Dialysis News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in